To confirm this, we treated a range of human AML cell lines with FX11 or an unrelated selective LDHA inhibitor (GSK2837808A) and measured both viable cell numbers and the percentage of dead cells 48 h later. The gene discussed is LDHA; the disease is acute myeloid leukemia.